Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo

Clinical Cardiology

obstructive hypertrophic cardiomyopathy

Advances in Hypertrophic Cardiomyopathy Therapy: VALOR-HCM May Be Just the Beginning

An abundance of promising studies are on the horizon

22-HVI-3276959_obstructive-HCM-strain-imaging_650x450

Mavacamten’s Effects Against Obstructive Hypertrophic Cardiomyopathy Persist Through 32 Weeks in VALOR-HCM

Latest results confirm and build on 16-week findings

Knowing the signs can save your life

How Autoimmune Disorders Impact Myocardial Infarction Treatment and Long-Term Outcomes

Largest study to date finds lower intervention rates, elevated long-term mortality

22-HVI-3167284_stroke-in-brain_650x450

Is It Time to Add ‘C’ for Cancer to the CHA2DS2 VASc Score?

Large data analysis finds cancer helps predict stroke risk in patients with atrial fibrillation

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-HVI-3073724 CQD 650×450

Recurrent Pericarditis: It’s Time to Recognize the Paradigm Shift in Imaging and Therapeutics

Targeted IL-1 blockers and CMR techniques allow more-tailored treatment strategies

22-HVI-3073818_atrial-fibrillation_650x450

Preexisting Atrial Fibrillation Predicts Worse Cardiac Outcomes After Noncardiac Surgery

Large cohort study argues for incorporating AF into perioperative risk scores

01_22Cov1.indd
May 6, 2022/Digestive

Cardiac Considerations for the Liver Transplant Patient

As the demographics of transplant recipients shift, their heart care must keep pace

22-HVI-2769712_hyptertrophic-cardiomyopathy_650x450

Mavacamten Significantly Reduces Patients’ Need for Septal Reduction Therapy Over 16 Weeks

Longer-term confirmation of VALOR-HCM could yield a noninvasive therapy for severe obstructive HCM

22-HVI-2713173_spontaneous-coronary-artery-dissection_650x450

Spontaneous Coronary Artery Dissection: Principles of Management

How Cleveland Clinic approaches the condition in the absence of randomized trial data

21-HVI-2500367-hypertrophic-cardiomyopathy-650×450

In Obstructive Hypertrophic Cardiomyopathy, One Size Does Not Fit All

Why we favor a tailored approach to relieve LVOT obstruction

BackPage 5 of 7Next

Advertisement

Ad